Apheresis — Collecting Your Cells for CAR-T

Apheresis is a blood-collection procedure, not an operation. Blood leaves your body through one line, a machine separates out the layer containing white cells, and everything else is returned through a second line. You stay awake. Nothing is cut. The cells collected that day are the raw material your CAR-T treatment is later made from.

Nobody explains this step in advance, and that is why it frightens people. Families are told a great deal about the infusion and the hospital stay, and almost nothing about the appointment that comes weeks earlier. So the first mental picture is usually wrong — a theatre, an anaesthetic, something taken out of the bone. None of that is what happens. It is closer to donating blood platelets than to any procedure in your cancer treatment so far.

Why your own cells are needed at all. CAR-T is made individually, from one patient, for that patient. The T cells in the collected fraction are sent to a laboratory, given a receptor that recognises a target on the cancer cells, grown in number and tested before release. There is no shelf stock and no substitute batch. That is also why the calendar is unforgiving: a collection that yields too few cells, or a batch that fails testing, restarts the sequence rather than delaying it by a day.

The medical name you may see on the form. Your paperwork may say leukapheresis, mononuclear cell collection or T-cell harvest. These all describe the same appointment. If a consent form uses a word you have not heard, ask the apheresis nurse to point to it on the machine — they do this every week and the explanation takes two minutes.

Said plainly, before anything else: CION Cancer Clinics does not provide CAR-T or any other cell therapy, does not perform apheresis for it, and quotes no price for any part of it. This page is orientation and referral guidance only, so that a family preparing for a collection appointment at an accredited centre knows what the day involves. Where referral is genuinely the right next step, we will say so and help you get the record in order first.

The machine itself usually runs for three to five hours. Plan for a full day at the hospital once tests, line placement, setup and observation are counted. Most people are collected in one session. Some are asked back for a second day, because the cell count in the bag has to clear a threshold before the batch is accepted.

The gap after collection is the part families under-plan. Disease does not pause while a batch is being made, so your team may give interim treatment to hold things steady — that is the subject of Bridging Therapy: Treatment While You Wait for CAR-T. Ask on collection day what the plan is for those weeks, rather than assuming there is nothing in between.

No. The needle going in is the only sharp part, and it feels like a blood test or a drip being sited. A central line, if one is used, is placed with local anaesthetic. What people actually notice is tingling around the lips and fingertips, feeling cold, and the tedium of lying still with both arms occupied.

Tell the nurse the moment anything changes rather than waiting to see whether it passes. Everything in the first six rows is routine, expected and treatable within minutes; the unit would far rather slow the machine down than have you endure something quietly. Patient-education guidance from bodies including NCCN and ESMO describes apheresis as a well-tolerated outpatient procedure in experienced hands.

1. 1

   Ask which medicines to hold, and get it in writing

   Steroids and some cancer treatments affect the cells being collected, so units often ask for a gap before the date. Blood thinners and blood-pressure medicines may also need adjusting. Never stop anything on your own reading — ask the treating team and keep their written instruction with you.

2. 2

   Eat, and drink well the day before

   This is usually not a fasting procedure — confirm with the unit, then eat a normal meal beforehand. Being well hydrated genuinely helps the veins run and reduces light-headedness. Calcium-rich food the day before is commonly advised for the same reason calcium is given during the run.

3. 3

   Bring one person, and expect them to do everything

   Both your arms may be occupied for hours. Someone else has to hold a phone, open a bottle, adjust a blanket and deal with the paperwork downstairs. Plan for that person to stay the whole day and to drive or arrange the journey home afterwards.

4. 4

   Dress for a cold room and a still body

   Loose sleeves that push above the elbow, layers you can add, warm socks. You cannot get up mid-run, so use the bathroom before you are connected and ask about the arrangement for the hours after that.

5. 5

   Ask about veins before the morning of the appointment

   Apheresis needs good flow in both arms. If your veins have been used heavily for chemotherapy, the unit may plan a temporary central line instead — a small separate procedure done under local anaesthetic. Raising this in advance avoids discovering it on the day.

6. 6

   Book the trip so a second session does not strand you

   Only a handful of centres in India are accredited for this, so most families travel. Keep the return open by at least two days in case you are called back. Practical planning for the wider journey is set out in Travelling to Another City for CAR-T: Practical Planning.

• The cell count in the bag falls short — you are asked back for a second session. Common, expected, and not a sign the treatment will not work.
• Blood counts are too low on the day — the unit postpones rather than running a collection that is unlikely to yield enough.
• Recent steroids or certain treatments — these can affect the cells being collected, which is why a washout gap is often required before the date.
• Veins that will not take a wide-bore needle — the plan changes to a temporary central line, adding a short procedure and usually a few hours.
• Infection or fever in the days before — collections are deferred until it has settled, because manufacturing has strict acceptance criteria.
• A manufacturing batch that fails release testing — uncommon, but when it happens the pathway restarts from a fresh collection, not from the infusion.
• Disease that moves during the manufacturing wait — the reason bridging treatment is planned rather than improvised.

Cost is the other thing families ask about here. The collection is usually billed as one component of an accredited centre's overall cell-therapy pathway rather than as a standalone item, and figures vary by centre and by scheme — treat any number you are quoted as indicative, as of August 2026, and ask for it in writing. CION quotes no price for CAR-T or for apheresis, because CION does not provide either.

No. CION Cancer Clinics does not provide, administer, stock or manufacture CAR-T or any other cell therapy, and does not perform apheresis for it. We quote no price for any part of that pathway. If a message, an agent or a forwarded price list tells you otherwise, it is wrong.

What we do is read your reports and give you a straight answer. Whether this diagnosis sits in a category where CAR-T is genuinely discussed at all. What an accredited centre would realistically ask of your family in time, travel and attendance. And what the treatment already offered to you is worth, as a written second opinion. Where referral to an accredited cell-therapy centre is the right next step, we say so, and help you assemble the record before you travel — because an incomplete file is one of the commonest reasons a first appointment achieves nothing.

It is also worth knowing where this treatment does not currently apply. Approved cell therapy in India today is concentrated in specific blood cancers; work in solid tumours remains largely investigational, which CAR-T for Solid Tumours: Where the Research Stands sets out honestly. The immunotherapy given as day care at CION Cancer Clinics is checkpoint-inhibitor treatment — a different class of treatment, with a different schedule and no admission of this kind. Response-assessment PET-CT during that treatment is coordinated at partner imaging centres rather than owned by CION. Our first consultation is free, takes 45 minutes, and carries no commitment to start treatment anywhere.

• Bridging Therapy: Treatment While You Wait for CAR-T — what happens in the weeks between your collection appointment and the finished batch coming back.
• Travelling to Another City for CAR-T: Practical Planning — accommodation, leave, money and the two separate trips this pathway asks of a family.
• CAR-T for Solid Tumours: Where the Research Stands — read this before paying for anything if the cancer in question is not a blood cancer.
• Immunotherapy at CION Cancer Clinics — the treatments CION does provide, how eligibility is assessed, and what a free first consultation covers.

This page is general information and does not replace a consultation. CION Cancer Clinics does not provide CAR-T or any cell therapy and does not perform apheresis for it; immunotherapy at CION means checkpoint-inhibitor treatment given as day care, with response-assessment PET-CT coordinated at partner imaging centres. No product or brand is named on this page. All timings and any cost references are indicative, as of August 2026, and every accredited centre runs its own protocol. Clinical framing follows NCCN and ESMO patient-education guidance and the CDSCO position in India. Only the treating haemato-oncologist, reviewing the complete case, can tell you what applies to you.

Most people reach this page the night before a collection appointment

Ask us what this diagnosis actually calls for. You will get a plain answer, including when the answer is that CAR-T is not relevant to your case.